Literature DB >> 8435642

How useful is activated charcoal?

J A Vale, A T Proudfoot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8435642      PMCID： PMC1676641          DOI： 10.1136/bmj.306.6870.78

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  25 in total

1.  Absorption inhibition and enhancement of elimination of sustained-release theophylline tablets by oral activated charcoal.

Authors:  D T Lim; P Singh; S Nourtsis; R Dela Cruz
Journal:  Ann Emerg Med       Date:  1986-11       Impact factor: 5.721

2.  Do gastric contents modify antidotal efficacy of oral activated charcoal?

Authors:  K T Olkkola; P J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

3.  Acceleration of digoxin clearance by activated charcoal.

Authors:  R L Lalonde; R Deshpande; P P Hamilton; W M McLean; D C Greenway
Journal:  Clin Pharmacol Ther       Date:  1985-04       Impact factor: 6.875

4.  Treatment of theophylline toxicity with oral activated charcoal.

Authors:  C N Sessler; F L Glauser; K R Cooper
Journal:  Chest       Date:  1985-03       Impact factor: 9.410

5.  Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose.

Authors:  R A Curtis; J Barone; N Giacona
Journal:  Arch Intern Med       Date:  1984-01

6.  Charcoal and isoniazid pharmacokinetics.

Authors:  N Scolding; M J Ward; A Hutchings; P A Routledge
Journal:  Hum Toxicol       Date:  1986-07

7.  Activated charcoal and syrup of ipecac in prevention of cimetidine and pindolol absorption in man after administration of metoclopramide as an antiemetic agent.

Authors:  P J Neuvonen; K T Olkkola
Journal:  J Toxicol Clin Toxicol       Date:  1984

8.  Effect of single and repeated doses of activated charcoal on the pharmacokinetics of doxepin.

Authors:  M Scheinin; R Virtanen; E Iisalo
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1985-01

9.  The effect of activated charcoal and hyoscine butylbromide alone and in combination on the absorption of mefenamic acid.

Authors:  N el-Bahie; E M Allen; J Williams; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

10.  Lack of effect of oral activated charcoal on imipramine clearance.

Authors:  M J Goldberg; G D Park; R Spector; L J Fischer; R D Feldman
Journal:  Clin Pharmacol Ther       Date:  1985-09       Impact factor: 6.875
View more
  5 in total

1.  Management of drug overdoses in accident and emergency departments in the United Kingdom.

Authors:  I Greaves; S Goodacre; P Grout
Journal:  J Accid Emerg Med       Date:  1996-01

2.  Compliance for single and multiple dose regimens of superactivated charcoal: a prospective study of patients in a clinical trial.

Authors:  Fahim Mohamed; M Roshini Sooriyarachchi; Lalith Senarathna; Shifa Azhar; M H Rezvi Sheriff; Nick A Buckley; Michael Eddleston
Journal:  Clin Toxicol (Phila)       Date:  2007       Impact factor: 4.467

3.  Severe theophylline poisoning: charcoal haemoperfusion or haemodialysis?

Authors:  R M Higgins; S Hearing; D J Goldsmith; B Keevil; M C Venning; P Ackrill
Journal:  Postgrad Med J       Date:  1995-04       Impact factor: 2.401

4.  Effects of Enriched Charcoal as Permanent 0.2% Feed-Additive in Standard and Low-Protein Diets of Male Fattening Turkeys: An On-Farm Study.

Authors:  Katharina Hinz; Jenny Stracke; Jule Katrin Schättler; Nicole Kemper; Birgit Spindler
Journal:  Animals (Basel)       Date:  2019-08-08       Impact factor: 2.752

5.  Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial.

Authors:  Michael Eddleston; Edmund Juszczak; Nick A Buckley; Lalith Senarathna; Fahim Mohamed; Wasantha Dissanayake; Ariyasena Hittarage; Shifa Azher; K Jeganathan; Shaluka Jayamanne; Mh Rezvi Sheriff; David A Warrell
Journal:  Lancet       Date:  2008-02-16       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.